NCT03312764
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +12 more
- Locations
-
- University of Nebraska Medical Center Omaha, Nebraska, United States
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
8,020 public trials
711 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT04763525
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
- General University Laiko Hospital Athens, Greece
NCT03164538
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT03792685
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +20 more
- Locations
-
- Clinical Research Centre, Medical University of Bialystok Bialystok, Polska, Poland
NCT01427699
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- University Hospital of Basel Basel, Switzerland
NCT04765631
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- INSERM U1033, pavillon F, Hôpital E. Herriot. 5, place d'Arsonval Lyon, France
NCT00141232
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetes, Type 2, +4 more
- Locations
-
- Pfizer Investigational Site Irvine, Ayrshire, United Kingdom
- Pfizer Investigational Site Farnworth, Bolton, United Kingdom
- Pfizer Investigational Site Thornhill, Cardiff, United Kingdom
- Pfizer Investigational Site Fowey, Cornwall, United Kingdom
NCT02993614
- Conditions
- Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Research Site Wilmington, Delaware, United States
- Research Site Melbourne, D1690r00015, Australia
- Research Site Mississauga, D1690r00015, Canada
- Research Site Gentofte Municipality, D1690r00015, Denmark
NCT00415428
- Conditions
- Cardiovascular Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, +5 more
- Locations
-
Not specified
Completed
Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets
NCT00442325
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Brain Diseases, +23 more
- Locations
-
- Pfizer Investigational Site Ioannina, Greece
- Pfizer Investigational Site Kallithea, Athens, Greece
- Pfizer Investigational Site Pireaus, Greece
- Pfizer Investigational Site Thessaloniki, Greece